PolyPid

Israel
Petaẖ Tiqva, Central District, Israel, 49348

Company profile

PolyPid company profile

PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics. PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.

Business identity

Contact email
[email protected]
Phone number
+972 7 4719 5700
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2008-01-01, Year

Headquarters

Postal code
49348
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
10
Total equity funding
$174.1M
Last funding
Post IPO Equity / $26.7M / 2025-06-16
Last equity funding
Post IPO Equity / $26.7M
Investors
9
Lead investors
4
Founders
1
Articles
113
Exited on
2020-06-26

Founders and investors

Founders

Noam Emanuel

Lead investors

Dafna Capital ManagementKreos CapitalRosalind Capital PartnersShavit Capital

Investors

Apple Core HoldingsAurum VenturesDafna Capital ManagementKreos CapitalShavit Capital